Differences in Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Chryseobacterium gleum and Chryseobacterium indologenes | Zendy

Jiung Lin | Zendy; ChungHsu Lai | Zendy; Chih-Hui Yang | Zendy; Yi-Han Huang | Zendy

Open Access

Differences in Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Chryseobacterium gleum and Chryseobacterium indologenes

Author(s) -

Jiung Lin,

ChungHsu Lai,

Chih-Hui Yang,

Yi-Han Huang

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02256-18

Subject(s) - chryseobacterium , microbiology and biotechnology , piperacillin , tigecycline , biology , levofloxacin , tazobactam , ciprofloxacin , medicine , antimicrobial , imipenem , antibiotic resistance , antibiotics , 16s ribosomal rna , bacteria , genetics , pseudomonas aeruginosa

Chryseobacterium infections are uncommon, and previous studies have revealed thatChryseobacterium gleum is frequently misidentified asChryseobacterium indologenes . We aimed to explore the differences in clinical manifestations and antimicrobial susceptibility patterns betweenC. gleum andC. indologenes .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research